all report title image
  • Published On : May 2022
  • Code : CMI5030
  • Industry : Medical Devices
  • Pages : 178
  • Formats :

Scalp Microneedling is a process that causes minor superficial injury to the scalp that stimulates hair follicles and thus promotes new hair growth, and increases the blood circulation in the scalp. It also helps in increased collagen synthesis. Microneedling also helps in absorption of products deep into the scalp. It is done with a dermaroller or dermapen, they come in different sizes. The choice of the depth of microneedling depends on the scalp condition of every patient. These microneedling devices consist of very fine multiple titanium needles that are completely safe for the skin and don't cause any damage to the skin.

The global scalp microneedling market is estimated to be valued at US$ 179.5 million in 2022 and expected to increase to US$ 336.3 million by 2030, witnessing a CAGR of 8.2% over the forecast period (2022-2030).

Figure 1. Global Scalp Microneedling Market Share (%), By Region, 2022

Scalp Microneedling  | Coherent Market Insights

The rising prevalence of hair loss disorders is expected to drive the growth of the global scalp microneedling market.

Alopecia areata is a type of autoimmune disorder that causes hair loss, often in clumps, the size and shape of a quarter. The amount of hair loss is different in everyone. Some people lose it only in a few spots. Therefore, increasing prevalence of hair loss will surge the demand for scalp microneedling devices, and is expected to drive the market growth over the forecast period.

For instance, according to a study published by Journal of Family Medicine and Primary Care, in October 2021, to evaluate the prevalence of hair loss and its associated risk factors among primary healthcare centre (PHC) attendance in the Jazan region in southwest Saudi Arabia, near the northern border of Yemen, a cross-sectional study was done. The data was obtained in a number of PHCs around the region during August and October 2020. A total of 729 people agreed to participate in this study. There were 483 respondents who said they had hair loss, accounting for 66.3 percent of the total sample. The most variable factor appears to be gender, with the majority of participants reporting hair loss being female (P < 0.001). Telogen effluvium was the most common kind of hair loss, followed by androgenic alopecia.

CMI table icon

Scalp Microneedling Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 179.5 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 8.2% 2030 Value Projection: US$ 336.3 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Dermaroller, Dermapen, Derma-stamp
  • By Size: Under 0.25 mm, 0.25mm-0.3mm, 0.75mm-1.0mm, 1.0mm-1.5mm, Above 1.5mm
  • By Needle Material: Silicon Microneedle, Metal Microneedle, Glass Microneedle
  • By End User: Hospitals, Dermatology Clinics, Others
Companies covered:

Dermapen, Dermaroller GmbH, Zcalp, Envision Medical Spa, MDPen Fractional Microdermal Needling, DermaConcepts, ConceptSkincare, Ramboll Environ, Inc., Edge Systems LLC., Weyergans High Care, and Bomtech Electronics Co., Ltd.

Growth Drivers:
  • Rising prevalence of hair loss disorders
  • High cases of chemotherapy-induced hair loss
  • Increasing clinical studies
Restraints & Challenges:
  • Possible side effects associated with scalp microneedling

Figure 2. Global Scalp Microneedling Market Share (%) Analysis, By Product Type, 2022

Scalp Microneedling  | Coherent Market Insights

High cases of chemotherapy-induced hair loss is expected to drive the growth of the global scalp microneedling market.

As stated by BioMed Central Ltd., a part of Springer Nature, in December 2019, chemotherapy is a major type of cancer treatment using chemical medications to affect cancer cell growth, division and reproduction. Hair loss is a major side effect of chemotherapy. According to the same source, the incidence of chemotherapy-induced hair loss is as high as 65% in patients receiving chemotherapy and in some is even up to 80–100% in patients receiving specific agents, such as doxorubicin and docetaxel.

Global Scalp Microneedling Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries across the globe. The coronavirus (COVID 19) pandemic and consequent lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. The coronavirus pandemic has also hindered the development, production, and supply of medical devices and other healthcare products and affected the growth of the healthcare business of many companies around the world.

Many dermatology clinics and services were halted due to their elective nature and severely affected the operations of many aesthetic clinics due to the reduced patient footfall. However, many dermatologists believe that COVID-19 may act as a springboard that will drastically increase patient footfall post-pandemic. For instance, according to the American Society of Plastic Surgeons, in 2020, the pandemic led to an increase in the acceptance of cosmetic procedures. The 2020 association’s survey of more than 1,000 women in the U.S. reported that 11% of the women are now more inclined and interested in nonsurgical procedures than before COVID-19.

Global Scalp Microneedling Market: Restraint

Possible side effects associated with scalp microneedling include bruising, oozing from the wounds, redness, swelling, and pain, which are expected to hamper the global scalp microneedling market growth. There’s also a risk that the wounds caused by the needles may form scar.

Key Players

Major players operating in the global scalp microneedling market include Dermapen, Dermaroller GmbH, Zcalp, Envision Medical Spa, MDPen Fractional Microdermal Needling, DermaConcepts, ConceptSkincare, Ramboll Environ, Inc., Edge Systems LLC., Weyergans High Care, and Bomtech Electronics Co., Ltd.

Microneedling is a minimally invasive therapy that involves superficial micro puncturing of the epidermis using a dermapen or a roller embedded with thin, tiny metal or silicon needles, according to the American Academy of Dermatology Association. The technique's main goal is to create peripheral stress on the skin in order to activate the skin's repair systems and increase underlying collagen production.

Scalp microneedling may also aid in the absorption of hair loss treatment products like minoxidil (Rogaine), topical steroids, and platelet-rich plasma. The needles used can range in length from less than 1 millimeter to a few millimeters. They are all contained in a handheld device, also called a roller, the device is rolled along the treatment area, creating small injuries. When rolled over the scalp or hairline, it creates tiny punctures that can make it easier for the medicinal qualities of topical and oils to reach the hair follicles. It is speculated that microneedling may provoke the release of factors that promote hair growth or perhaps directly stimulate hair growth as a result of the small injury caused.

Market Dynamics

The increasing prevalence of malnutrition condition is expected to drive the growth of global scalp microneedling market over the forecast period, as lack of proper nutrition may result in hair loss problems, which is expected to drive the demand for scalp microneedling devices for its treatment. For instance, according to the fact sheet provided by World Health Organization, in June 2021, Malnutrition, in all its forms, includes under nutrition (wasting, stunting, and underweight), inadequate vitamins or minerals, overweight, obesity, and resulting diet-related non-communicable diseases. According to the same source, globally in 2020, 149 million children under 5 were estimated to be stunted (too short for age), 45 million were estimated to be wasted (too thin for height), and 38.9 million were overweight or obese.

Key features of the study:

  • This report provides an in-depth analysis of the global scalp microneedling market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global scalp microneedling market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include Dermapen, Dermaroller GmbH, Zcalp, Envision Medical Spa, MDPen Fractional Microdermal Needling, DermaConcepts, ConceptSkincare, Ramboll Environ, Inc., Edge Systems LLC., Weyergans High Care, and Bomtech Electronics Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global scalp microneedling market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global scalp microneedling market

Detailed Segmentation:

  • Global Scalp Microneedling Market, By Product Type:
    • Dermaroller
    • Dermapen
    • Derma-stamp
  • Global Scalp Microneedling Market, By Size:
    • Under 0.25 mm
    • 25mm-0.3mm
    • 75mm-1.0mm
    • 0mm-1.5mm
    • Above 1.5mm
  • Global Scalp Microneedling Market, By Needle Material:
    • Silicon Microneedle
    • Metal Microneedle
    • Glass Microneedle
  • Global Scalp Microneedling Market, By End User:
    • Hospitals
    • Dermatology Clinics
    • Others
  • Global Scalp Microneedling Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Dermapen
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Dermaroller GmbH
    • Zcalp
    • Envision Medical Spa
    • MDPen Fractional Microdermal Needling
    • DermaConcepts
    • ConceptSkincare
    • Ramboll Environ, Inc.
    • Edge Systems LLC.
    • Weyergans High Care
    • Bomtech Electronics Co., Ltd

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global scalp microneedling market is estimated to be valued at US$ 179.5 Million in 2022 and expected to exhibit a CAGR of 8.2% between 2022 and 2030.
Rising prevalence of hair loss disorders, high cases of chemotherapy-induced hair loss, increasing clinical studies are major growth driving factors for the market.
Dermaroller is the major product type segment in the market.
Possible side effects associated with scalp microneedling is the major factor restraining the market growth.
Major players operating in the market include Dermapen, Dermaroller GmbH, Zcalp, Envision Medical Spa, MDPen Fractional Microdermal Needling, DermaConcepts, ConceptSkincare, Ramboll Environ, Inc., Edge Systems LLC., Weyergans High Care, and Bomtech Electronics Co., Ltd.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo